PATH
Menu

Filter browse results

Total results with these characteristics: 72

Subject: Emerging and epidemic diseases > Malaria

Page 1 of 4
10 Tips for Successful Malaria Vaccine Advocacy

This booklet presents advocacy tips, success stories, and examples of efforts to bridge the worlds of science and policymaking and to help ensure that policymakers at national, regional, and international levels have the information needed to make timely and informed decisions as soon as a first malaria vaccine becomes available for use.

Publication date: February 2012

Region: Africa

2012 Annual Report: Innovation in Motion

PATH’s health solutions touched the lives of more than 118 million people around the world in 2012. Our 2012 annual report highlights our milestones in three focus areas: diarrheal disease and pneumonia; family health; and malaria. It also features innovations in technology development and country-based health programs, a financial summary, and information about our donors, leadership, and global presence.

Publication date: May 2013

Region: Global

Part of series: Annual reports

Accelerating Malaria Elimination in Africa: PATH Partners With Malaria-Endemic Countries, the Private Sector, and the Global Community in the Quest for a Malaria-Free World

This fact sheet provides an overview of the work of PATH's Malaria Control and Elimination Partnership in Africa (MACEPA) to develop and document approaches for reducing malaria illnesses and deaths, with the long-term goal of malaria elimination.

Publication date: April 2014

Region: Africa

Adaptation of Immunoassays for Multiplexed Diagnosis of a Diverse Panel of Pathogens Associated With Acute Febrile Illness

This poster summarizes PATH’s recent activities as part of a consortium lead by the University of Washington to develop the DxBox, a system comprising a portable instrument and low-cost disposable cards. The prototype is being developed to diagnose typhoid fever, dengue fever, rickettsial diseases, malaria, measles, and influenza. PATH’s contributions are immunoassay development, field studies, and user needs assessment. Presented at The American Society of Tropical Medicine and Hygiene (ASTMH), November 12, 2006; Atlanta, GA.

Author: Gerlach JL, Singhal MC, Watts K, et al

Publication date: November 2006

Region: Global

Analysis of WHO Policy Development Process for a New Intervention

The PATH Malaria Vaccine Initiative commissioned this analysis to begin elucidating the World Health Organization (WHO) process for developing policy guidelines for a malaria vaccine. The analysis considered past WHO recommendations on new interventions and assessed potential implications for a malaria vaccine.

Author: Milstien J, Brooks A, Cardenas V, Cheyne J

Publication date: May 2008

Region: Global

Business Investing in Malaria Control: Economic Returns and a Healthy Workforce for Africa

This report in the Roll Back Malaria Progress & Impact Series examines how private-sector investment in malaria control has improved cost-effectiveness at companies operating in malaria-endemic regions in Africa.

Author: Mouzin E, Sedlmayr R, Miller J, et al

Publication date: May 2011

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

Clinical Trials: Steps in Malaria Vaccine Development

Clinical trials are a critical source of data for decisions around vaccine development. This fact sheet provides information about the phases of clinical trials.

Publication date: October 2009

Region: Global

Community Health Workers' Manual

PATH developed this manual for community health workers to facilitate and support the implementation of the AIDS, Population, and Health Integrated Assistance (APHIA) II project’s community-based activities in Eastern, Nyanza, and Western provinces of Kenya. The manual was developed with funding from the US Agency for International Development. It is available as one large file or as 17 smaller files.

Publication date: July 2007

Region: Africa

Community Perceptions of Malaria and Vaccines in the South Coast and Busia Regions of Kenya

Malaria is a leading cause of morbidity and mortality in children younger than five years in Kenya. Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study, published in Malaria Journal, explores sociocultural and health communications issues among individuals who are responsible for or influence decisions on childhood vaccination at the community level.

Author: Ojakaa DI, Ofware P, Machira YW, et al

Publication date: May 2011

Region: Africa

Country Planning for Health Interventions Under Development: Lessons From the Malaria Vaccine Decision-Making Framework and Implications for Other New Interventions

This paper describes research into the anticipated processes and data needed to inform decision-making on malaria vaccines, the most advanced of which is still in phase 3 trials.

Author: Brooks A, Ba-Nguz A

Publication date: February 2012

Region: Africa

A Decade of Partnership and Results

Part of the Roll Back Malaria Progress & Impact Series, this report demonstrates the dramatic successes achieved by the malaria community over the past ten years. As a result of greater commitment and increased resources being made available to national malaria control programs, interventions have reached vulnerable populations and thousands of lives have been saved. The report details the evolution and effectiveness of the Roll Back Malaria Partnership over the years, demonstrating how a strong, well-organized community can help deliver broad health benefits while relieving overburdened health systems.

Author: White Johansson EW, Newby H, Carvajal L, et al

Publication date: September 2011

Region: Global

Part of series: Roll Back Malaria Progress & Impact Series

Delivering Health Solutions to Those in Need: Our Work in Malaria Control, Child Nutrition, and HIV Prevention Builds Healthier Communities

This fact sheet provides an overview of PATH's work in Zambia, including our work to support data-driven malaria control measures, improve child health and nutrition, prevent HIV infection, and create better information management systems.

Publication date: December 2011

Region: Africa

Detection and Characterization of Acute Febrile Illness in Western Kenya

This poster presents a study to collect and characterize specimens from febrile patients who were suspected to have malaria, pedigree specimens against a panel of nucleic acid and serological markers, and draw early insights into data that would be generated by a multiplex diagnostic platform. Presented at The American Society of Tropical Medicine and Hygiene, December 7, 2008; New Orleans, LA.

Author: Gerlach JL, Waitumbi J, Koros J, et al

Publication date: December 2008

Region: Global

Developing a Point-of-Care Multiplexed Diagnostic System for Low-Resource Settings in Developing Countries

A report on the selection and evaluation of target markers for a multiplex diagnostic platform under development. Based on the DxBox platform being developed as part of a public-private consortium lead by the University of Washington. Presented at the Molecular Medicine Tri-Conference, March 25, 2008; San Francisco, CA.

Author: Gerlach JL, Anyona S, Koros J, et al

Publication date: March 2008

Region: Global

Developing Drugs for Neglected Diseases: PATH Advances High-Quality, Affordable Treatments for the Developing World

This fact sheet describes PATH's drug development program, including our work to develop new treatments for malaria, kala-azar (visceral leishmaniasis), and diarrheal disease.

Publication date: September 2012

Region: Global

Part of series: Areas of focus fact sheets

Diagnosis of Plasmodium Falciparum Malaria in the Lao People's Democratic Republic (PDR) Using Rapid Diagnostic Assays

This study evaluated the performance of PATH’s rapid diagnostic assay detecting histidine rich protein 2 (HRP-2) antigen when used by local health care providers in a rural field setting in Lao PDR and examined rapid diagnostic assays as a strategy to identify participants for in vivo treatment trials in a rural field site.

Author: Labbé AC, Pillai DR, Hongvangthong B, et al

Publication date: January 1999

Region: Global

Directions in Global Health (Volume 1, Issue 1)

The January 2004 issue of PATH's programmatic newsletter focuses on five projects: preventing HIV and AIDS in the Philippines, evaluating a malaria vaccine candidate, increasing youth access to services through pharmacies, advancing the Ultra Rice technology, and using theater to encourage social change.

Publication date: January 2004

Region: Global

Part of series: Directions in Global Health

Directions in Global Health (Volume 10, Issue 1)

This issue of Directions in Global Health features work by OneWorld Health, PATH’s drug development program, to lead development of innovative methods to enhance the supply of artemisinin, a key ingredient in malaria treatments. It includes a commentary by Dr. Ponni Subbiah, who directs PATH’s drug development efforts. Other articles cover work to improve cervical cancer screening, protect infants from respiratory syncytial virus, increase access to family planning, and strengthen and expand use of human milk banking.

Publication date: May 2013

Region: Global

Part of series: Directions in Global Health

Directions in Global Health (Volume 3, Issue 1)

This special issue of Directions in Global Health features PATH's work in malaria prevention and control. It describes PATH's partnerships, experience in Zambia, clinical trial activities, efforts to prepare for vaccine introduction, and advocacy efforts.

Author: PATH

Publication date: May 2006

Region: Global

Part of series: Directions in Global Health

Directions in Global Health (Volume 4, Issue 1)

This special issue of Directions in Global Health highlights PATH's vaccine partnership efforts: PATH Malaria Vaccine Initiative (MVI), pneumococcal vaccine development project, Meningitis Vaccine Project, cervical cancer vaccine project, and Rotavirus Vaccine Program. The issue also features a case study of the vaccine vial monitor.

Author: PATH

Publication date: May 2007

Region: Global

Part of series: Directions in Global Health

Page 1 of 4